Stem Cell Therapy
Minimally manipulated adipocytes derived from autologous adipose tissue were injected into a sterile physiological saline solution for cell therapy
EHL-Keycell is a cell therapy drug that injects minimally manipulated adipocytes derived from autologous adipose tissue into a sterile physiological saline, which has been separated from the patient with minimal manipulation. It is mainly used in plastic surgeries to treat subcutaneous fat deficiency in areas such as the forehead, cheeks and nasolabial fold.
In addition, this process is safer and more effective than conventional medical devices, as the patient’s own adipose tissue is collected, and the cells isolated by simple manipulation before being suspended in a sterile physiological saline solution.
In 2017, EHL-Keycell will apply to the Ministry of Food and Drug Safety for approval as a biological agent.